BDXLARGE

Becton, Dickinson and Company

HealthcareMedical - Instruments & Supplies
$140.71
$0.02(+1.67%)
52W$100.31
$205.52
Updated Jun 22, 02:00 AM
RSI43
RS Rating43/99
Beta0.44
Volatility51%
F-Score7/9
Mkt Cap$51.0B
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Becton, Dickinson and Company is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 43), showing significant lag compared to the market leaders. Earnings contraction of 204% provides fundamental context to the price action. Investors should exercise caution due to high volatility (51% annualized), which requires wider risk management.

Relative Strength
43
out of 99
Lagging
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
0.44
vs S&P 500
LOW VOL
52W Position
38%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$148.67
50 SMA > 100 SMA$157.09
100 SMA > 150 SMA$156.25
150 SMA > 200 SMA$146.02

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$146.73-4.10%BELOW
50 SMA$148.67-5.35%BELOW
100 SMA$157.09-10.43%BELOW
150 SMA$156.25-9.94%BELOW
200 SMA$146.02-3.63%BELOW

Price Performance

1D+1.7%
1W-2.3%
1M+1.1%
3M-8.9%
6M-5.9%
YTD-6.0%
1Y+38.2%
3Y-3.2%
52-Week Trading Range38% from low
$140.71
52W Low$100.31
52W High$205.52

Technical Indicators

RSI (14)NEUTRAL
43.3
305070
Setup ScoreCOOL
3/10
Base depth: 13.6%

Risk Profile

Beta
0.44
52W Vol
51%
ATR
$3.42
Max DD (1Y)
-30%

Volume Analysis

Today
3.16M
50D Avg
2.64M
Vol Ratio
1.20x
Liquidity
LIQUID

Earnings Momentum

Q3'25+19%
$2.00
Q4'25+19%
$1.72
Q1'26+29%
$1.34
Q2'26-204%
$-1.11
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+7.82%
5 Years:+6.32%
3 Years:+4.99%
TTM:+2.39%

Compounded Profit Growth

10 Years:+5.70%
5 Years:+16.56%
3 Years:-0.28%
TTM:-24.62%

Stock Price CAGR

10 Years:+3.58%
5 Years:-0.13%
3 Years:-3.15%
1 Year:+38.18%

Return on Equity

10Y Avg:7.1%
5Y Avg:7.0%
3Y Avg:6.3%
Last Year:4.5%

Key Metrics

Market Cap$51.0B
Gross Margin45.4%
Net Margin7.7%
Piotroski F-Score7/9

Frequently Asked Questions

Is BDX in an uptrend right now?

BDX has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is BDX overbought or oversold?

BDX's RSI (14) is 43. The stock is in neutral territory, neither overbought nor oversold.

Is BDX outperforming the market?

BDX has a Relative Strength (RS) Rating of 43 out of 99. BDX is currently lagging the broader market.

Where is BDX in its 52-week range?

BDX is trading at $140.71, which is 68% of its 52-week high ($205.52) and 38% above its 52-week low ($100.31).

How volatile is BDX?

BDX has a Beta of 0.44 and 52-week volatility of 51%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.